Michele Ostraat, Ph.D., recently joined RTI International as director of engineering research for the Center for Aerosol Technology. In that role she will manage 25 staff members who conduct a wide range of research on aerosol technology and nanotechnology platforms.
Engineers from SEMATECH and the International SEMATECH Manufacturing Initiative (ISMI) will deliver more than 30 papers and posters during the SPIE Advanced Lithography conferences next week in San Jose, CA, with an overriding emphasis on the manufacturability of current and emerging technology options to take the industry to 32nm half-pitch and beyond - including extreme ultraviolet (EUV) lithography, 193nm optical lithography extensions, and related areas of metrology, inspection, and process control.
With 32nm technologies ramping within the next two years, implementing production-worthy techniques to address advanced patterning requirements becomes device makers' primary concern. On February 27th Applied Materials, Inc. will host a full day of technical presentations to discuss strategies and solutions to meet these scaling challenges.
NaturalNano, Inc., a developer of advanced nanomaterials and controlled release nanotechnologies, announced the Company's performance goals for fiscal year 2008. Currently, several strategic alliances are in negotiation and product evaluation, which are expected to close during the first half of 2008.
Nanometrics Incorporated, a leading supplier of advanced metrology equipment to the semiconductor industry, today announced its financial results for the fourth quarter and full year ended December 29, 2007.
Copper theft is a community problem that is continuing to grow. Thieves have stolen air conditioners out of churches, equipment of out schools and wiring out of streetlights. Oncor, with its miles of distribution and transmission lines, is also a target for these thieves.
pSivida Limited today announced the receipt of US$500k as the first quarterly research and development payment from Pfizer under the terms of the exclusive worldwide Collaborative Research and License Agreement signed in April 2007 for pSivida's controlled drug delivery technologies in ophthalmic applications.